Skip to main content
Clinical Trials/NCT04156061
NCT04156061Active, not recruitingNot Applicable

Effect of the SCOT-HEART 2 Trial on Lifestyle and Risk Factor Modification.

University of Edinburgh2 sites in 1 country400 target enrollmentStarted: September 28, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
400
Locations
2
Primary Endpoint
Proportion of patients who meet National Institute for Heath and Care Excellence (NICE) recommendations on risk factor modifications

Study Overview

Brief Summary

This study will recruit 400 participants who are taking part in the Computed Tomography Coronary Angiography for the Prevention of Myocardial Infarction (SCOT-HEART 2) trial. The investigator will assess diet, activity and habits at the start of the study and 6 months later. This will help us understand the effects taking part in the study may have on lifestyle. In addition, for participants who have CT scans, the investigator will present the results of the heart from the CT scan. This will help us understand how best to explain the results of the CT scan to patients.

Detailed Description

This is a sub-study of the SCOT-HEART 2 trial (which aims to determine the best way to prevent heart attacks).

The purpose of this sub-study is to determine the effect of getting information on heart disease risk on lifestyle. At present doctors usually use a "risk score" to identify people at risk of heart disease who may benefit from medical treatment. In the SCOT-HEART 2 study the investigator will compare this "risk score" to a specialised heart scan (a computed tomography coronary angiogram or CTCA scan). In this study the investigator would like to understand more about the effects of receiving this information about the heart on lifestyle, including effects on smoking, diet and activity.

This study will recruit 400 participants who are taking part in the SCOT-HEART 2 trial. The investigator will assess lifestyle by using a detailed questionnaire which will be done at the start of the study and 6 months later. The investigator will also perform some simple investigations including a carbon monoxide breath test, blood pressure tests and measurements of activity such as step counts. This will help us understand the effects on lifestyle of getting information about a "risk score" or having a CT scan. In addition, for people who have CT scans the investigator will either provide a verbal explanation of the results, as is usual, or show pictures of the heart from the CT scan. This will help us understand how best to explain the results of the CT scan to partipants.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
40 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • MUST BE ENROLLED IN SCOTHEART 2 TRIAL

Exclusion Criteria

  • MUST BE ENROLLED IN SCOTHEART 2 TRIAL

Outcomes

Primary Outcomes

Proportion of patients who meet National Institute for Heath and Care Excellence (NICE) recommendations on risk factor modifications

Time Frame: 6 months

The primary endpoint will be the proportion of patients who meet NICE recommendations on diet, smoking, weight and activity levels (%)

Secondary Outcomes

  • Smoking cessation(6 months)
  • Diabetic control(6 months)
  • Exercise(6 months)
  • Weight loss(6 months)
  • Blood pressure control(6 months)
  • Lipid levels(6 months)
  • Adherence to medications(6 months)
  • Quality of life/Anxiety and Depression(6 months)
  • ASSIGN score(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Effect of the SCOT-HEART 2 Trial on... | Clinical Trial